Brief: Chimeric Therapeutics Says Entitlement Offer To Raise A$10 Mln
25/10/2023 02:19
Oct 25 (Reuters) - Chimeric Therapeutics Ltd CHM.AX :
* ENTITLEMENT OFFER TO RAISE APPROXIMATELY A$10 MILLION
* OFFER PRICE OF A$0.028 PER NEW SHARE
Source text for Eikon: ID:nASXQxTjx
Further company coverage: CHM.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Chimeric Therapeutics
See all newsBrief: Chimeric Therapeutics Says Phillip Hains Appointed Interim Chairman
Brief: Chimeric Therapeutics Posts Prelim Loss For Year Of A$18.8 MLN
Brief: Chimeric Therapeutics Intends To Enter Negotiations With Its Creditors
Brief: Chimeric Therapeutics Seeks Trading Halt
Australia's Chimeric Therapeutics rises on positive data for its cell therapy clinical trial